Role of parametric imaging in contrast-enhanced sonography of hepatic focal nodular hyperplasia

Journal of Clinical Ultrasound

Volumn 34, Issue 8, 2006, Pages 367-373

  Huang Wei, Cecile ^a   Bleuzen, Aurore ^a   Olar, Monica ^a   Portalez, Daniel ^b   Roumy, Jerome ^c   Trillaud, Herve ^d   Tranquart, François ^a  

^a CHU BRETONNEAU   (France)

^b CLINIQUE PASTEUR   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Contrast media; Focal nodular hyperplasia; Liver; Parametric images; Sonography

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HUMAN; MALE; NODULAR HYPERPLASIA; PERFUSION; SENSITIVITY AND SPECIFICITY; ULTRASOUND SCANNER;

ADULT; AGED; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PHOSPHOLIPIDS; SOFTWARE; SULFUR HEXAFLUORIDE;

EID: 33749165769     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20256     Document Type: Article

References (24)

1. Ros PR, Menu Y, Vilgrain V, et al. Liver neoplasms and tumor-like conditions. Eur Radiol 2001;11(Suppl 2): S145.
2. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975;59:995.
3. Golli M, Mathieu D, Anglade MC, et al. Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology 1993;187:113.
4. Bertolotto M, Dalla Palma L, Quaia E, et al. Characterization of unifocal liver lesions with pulse-inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 2000;10:1369.
5. Strobel D, Krodel U, Martus P, et al. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors. J Clin Ultrasound 2000;28:1.
6. Wilson SR, Burns PN. Liver mass evaluation of ultrasound: the impact of microbubble contrast agents and pulse-inversion imaging. Semin Liver Dis 2001;21:147.
7. Dill-Macky MJ, Burns PN, Khalili K, et al. Focal hepatic masses: enhancement patterns with SH U508A and pulse-inversion US. Radiology 2002;222:95.
8. Tanaka S, Ioka T. Dynamic sonography of hepatic tumors. AJR Am J Roentgenol 2001;176:1191.
9. Uggowitzer M, Kugler C, Gröll R, et al. Sonographic evaluation of focal nodular hyperplasia (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist). Br J Radiol 1998;71:1026.
10. Bartolotta TV, Midiri M, Scialpi M, et al. Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 2004;14:583.
11. Klein D, Jenett M, Gassel HJ, et al. Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol 2004;14:1082.
12. Kim SH, Lee JM, Lee JY, et al. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR Am J Roentgenol 2005;184:1077.
13. Bleuzen A, Tranquart F. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 2004;14(Suppl 8): P53.
14. Phillips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol 2004;14(Suppl 8):P4.
15. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473.
16. Kudo M, Tomita S, Tochio H, et al. Sonography with intra-arterial infusion of carbon dioxide microbubbles: value in differential diagnosis of hepatic tumours. AJR Am J Roentgenol 1992;158:65.
17. Brannigan M, Burns P, Wilson S. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 2004;24:921.
18. Von Herbay A, Vogt C, Haussinger D. Pulse Inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 2002;21:1191.
19. Quaia E, Bertolotto M, Dalla Palma L. Characterization of liver hemangiomas with pulse-inversion harmonic imaging. Eur Radiol 2002;12:537.
20. Quaia E, Degobbis F, Tona G, et al. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Med 2004;107:155.
21. Albrecht T, Oldenburg A, Hohmann J, et al. Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur Radiol 2003;13(Suppl 3):79.
22. Nicolau C, Catala V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004;14:1092.
23. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420.
24. Bartolotta TV, Midiri M, Quaia E, et al. Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol 2005;15:685.